Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6674)	1/11/1999 9:49:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

Cramer on today's PFE Action Wrong! Still Too Hot in the Kitchen By James J. Cramer Growth stocks as a group often trade together. If you see the drugs work, then you can take the foods. If you see health care working, you can take the waste stocks. And when tech works, you can buy drugs or foods. Now, however, it looks like the competition within growth stocks has gotten too great. I see people selling their drug stocks to buy other new growth stocks, like Yahoo! (YHOO:Nasdaq) and America Online (AOL:NYSE). There simply don't seem to be enough assets to go around to buoy both Pfizer(PFE:NYSE) and Broadcast.com (BCST:Nasdaq). I can't hide from you that I have discomfort when the drugs are down. I love it when the drugs and the banks are up, and Monday both groups are getting clocked. I also don't like Ron Insana's almost defensive nature of asking whether a down-100 day means anything. I always get great comfort when the press guys make too much of a down-100 day. Now they are not making enough of it, given that -- excluding GM (GM:NYSE) and Alcoa (AA:NYSE) -- we have one ugly day